<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJS</journal-id>
<journal-id journal-id-type="hwp">spijs</journal-id>
<journal-id journal-id-type="nlm-ta">Int J Surg Pathol</journal-id>
<journal-title>International Journal of Surgical Pathology</journal-title>
<issn pub-type="ppub">1066-8969</issn>
<issn pub-type="epub">1940-2465</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1066896911427036</article-id>
<article-id pub-id-type="publisher-id">10.1177_1066896911427036</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Reports</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Combined Aldosterone and Cortisol Secretion by Adrenal Incidentaloma</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Vicennati</surname><given-names>Valentina</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1066896911427036">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Repaci</surname><given-names>Andrea</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1066896911427036">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>di Dalmazi</surname><given-names>Guido</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1066896911427036">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Rinaldi</surname><given-names>Eleonora</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1066896911427036">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Golfieri</surname><given-names>Rita</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1066896911427036">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Giampalma</surname><given-names>Emanuela</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1066896911427036">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Minni</surname><given-names>Francesco</given-names></name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff1-1066896911427036">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Marrano</surname><given-names>Nicola</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1066896911427036">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Santini</surname><given-names>Donatella</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1066896911427036">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Pasquali</surname><given-names>Renato</given-names></name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff1-1066896911427036">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-1066896911427036"><label>1</label>University Alma Mater Studiorum, Bologna, Italy</aff>
<author-notes>
<corresp id="corresp1-1066896911427036">Valentina Vicennati, Division of Endocrinology, Department of Clinical Medicine, S. Orsola-Malpighi Hospital, University Alma Mater Studiorum, Via Massarenti 9, 40138 Bologna, Italy Email: <email>vicennati@aosp.bo.it</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>6</month>
<year>2012</year>
</pub-date>
<volume>20</volume>
<issue>3</issue>
<fpage>316</fpage>
<lpage>319</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>A 70-year-old woman was referred to the authors’ unit following hospitalization for cardiac failure, high urinary free cortisol concentrations and severe hypokaliemia. A computed tomography scan of the abdomen showed an adrenal adenoma. The 24-hour urinary free cortisol values were high and plasma cortisol levels failed to suppress following 1 mg dexamethasone test. Aldosterone to plasma renin activity ratio was also pathologic, confirmed by saline load. She showed no symptoms of glucocorticoid excess. She was diagnosed with combined primary hyperaldosteronism and Cushing’s syndrome. Cases of adrenal incidentalomas co-secreting cortisol and aldosterone are rare; they should be addressed in patients undergoing adrenal surgery for Conn’s syndrome to avoid adrenal insufficiency after removal of the tumor.</p>
</abstract>
<kwd-group>
<kwd>adrenal incidentaloma</kwd>
<kwd>Cushing’s syndrome</kwd>
<kwd>Conn’s syndrome</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1066896911427036" sec-type="intro">
<title>Introduction</title>
<p>Among forms of endocrine hypertension, the most frequent are an excess of glucocorticoids, mineralocorticoids, and catecholamines.<sup><xref ref-type="bibr" rid="bibr1-1066896911427036">1</xref></sup> The simultaneous production by adrenal adenomas of both cortisol and aldosterone is wrongly thought to be rare.<sup><xref ref-type="bibr" rid="bibr2-1066896911427036">2</xref><xref ref-type="bibr" rid="bibr3-1066896911427036"/>-<xref ref-type="bibr" rid="bibr4-1066896911427036">4</xref></sup> From the histological point of view, it is not easy to discriminate these mixed forms. We report a case of a woman with simultaneous hyperaldosteronism and Cushing’s syndrome caused by adrenal adenoma. She underwent surgery, and glucocorticoid replacement was unnecessary.</p>
</sec>
<sec id="section2-1066896911427036" sec-type="materials|methods">
<title>Materials and Methods</title>
<p>A 70-year-old woman was hospitalized for cardiac failure and severe hypokaliemia. She had a history of obesity associated with metabolic syndrome (dyslipidemia, hypertension, type 2 diabetes). Two years earlier, she underwent a computed tomography scan for abdominal pain, and an adrenal tumor was incidentally found (maximum diameter of 15 mm), radiologically consistent with adenoma. During hospitalization, high urinary free cortisol (UFC) levels were found. A computed tomography scan of the abdomen was thus performed, showing an enlargement of the left adrenal mass (from 15 to 29 mm; <xref ref-type="fig" rid="fig1-1066896911427036">Figure 1</xref>, upper panel).</p>
<fig id="fig1-1066896911427036" position="float">
<label>Figure 1.</label>
<caption><p>Computed tomography scan of adrenal tumor (upper panel) and <sup>131</sup>I-6-β-iodomethyl-norcholesterol (lower panel) scintigraphy</p>
<p>Abdominal computed tomography showed a round, well-defined mass of 24.5 × 29 mm diameter in the left adrenal gland. <sup>131</sup>I-6-β-iodomethyl-norcholesterol scan showed the increased uptake at left adrenal level, without inhibition of the controlateral adrenal gland.</p>
</caption>
<graphic xlink:href="10.1177_1066896911427036-fig1.tif"/>
</fig>
<p>Following discharge from hospital, the patient was admitted to our unit for functional evaluation of the adrenal tumor that was never evaluated before.</p>
<p>Her medications included aspirin (100 mg/d), candesartan and hydrochlorothiazide (16 mg + 12.5 mg/d, respectively), amlodipine (5 mg/d), atenolol (100 mg/d), doxazosin (4 mg/d), atorvastatin (10 mg/d), gliquidone (15 mg/d), lansoprazole (30 mg/d), and potassium supplementation (48 mEq/d). On admission, her body weight was 84 kg, body mass index 33.6 kg/m<sup>2</sup>, waist circumference 103 cm, hip circumference 109 cm (waist-to-hip ratio = 0.94); she had bilateral malleolar edema. Arterial blood pressure was 150/80 mm Hg, sinusal rhythm (76 beats/min). There were no buffalo humps and no rubra striae.</p>
<p>Functional evaluation of adrenal activity was performed without any pharmacological interference, in accordance with the cardiologist. Potassium supplementation was continued.</p>
</sec>
<sec id="section3-1066896911427036" sec-type="results">
<title>Results</title>
<p>Biochemical parameters were normal. Lipid profile was normal, except high-density lipoprotein cholesterol levels (44 mg/dL). Catecholamines and their urinary metabolites were normal. Fasting basal cortisol levels were repeatedly high as well as UFC/24 hours, and cortisol suppression after 1 mg dexamethasone (11:00 <sc>pm</sc>) was partial (<xref ref-type="table" rid="table1-1066896911427036">Table 1</xref>); the aldosterone to plasma renin activity ratio (ARR), following 2 hours orthostatism, was abnormally high (<xref ref-type="table" rid="table1-1066896911427036">Table 1</xref>). The saline infusion test also resulted in a partial suppression of aldosterone levels (from 295 to 95 pg/mL; <xref ref-type="table" rid="table1-1066896911427036">Table 1</xref>).</p>
<table-wrap id="table1-1066896911427036" position="float">
<label>Table 1.</label>
<caption><p>Hormonal and Electrolyte Assessment Before and After Surgical Removal of the Adenoma</p></caption>
<graphic alternate-form-of="table1-1066896911427036" xlink:href="10.1177_1066896911427036-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Parameters</th>
<th align="center" colspan="2">Before Surgery</th>
<th align="center">After Surgery</th>
<th align="center">Normal Range</th>
</tr>
</thead>
<tbody>
<tr>
<td>Na (mmol/L)</td>
<td>142</td>
<td>145</td>
<td>144</td>
<td/>
</tr>
<tr>
<td>K (mmol/L)</td>
<td>3.8<sup><xref ref-type="table-fn" rid="table-fn2-1066896911427036">a</xref></sup></td>
<td>4.5</td>
<td>4.1</td>
<td/>
</tr>
<tr>
<td>ACTH (pg/mL)</td>
<td>33</td>
<td>15</td>
<td>17</td>
<td>5-60</td>
</tr>
<tr>
<td>Cortisol (ng/mL)</td>
<td>347</td>
<td>201</td>
<td>101</td>
<td>62-194</td>
</tr>
<tr>
<td>UFC/24 hours (µg/day)</td>
<td>2285</td>
<td>1776</td>
<td>35</td>
<td>36-137</td>
</tr>
<tr>
<td>DHEA (µg/mL)</td>
<td>2.3</td>
<td>2.5</td>
<td>2.5</td>
<td>0.7-4</td>
</tr>
<tr>
<td>17-OHP (ng/dL)</td>
<td>90</td>
<td>72</td>
<td>70</td>
<td>50-240</td>
</tr>
<tr>
<td>Androstenedione (ng/dL)</td>
<td>50</td>
<td/>
<td>83</td>
<td>30-330</td>
</tr>
<tr>
<td>Plasma renin activity (ng/mL/h)</td>
<td>&lt;0.2</td>
<td>0.21</td>
<td>0.35</td>
<td>1.3-3.9</td>
</tr>
<tr>
<td>Aldosterone (pg/mL)</td>
<td>299</td>
<td>129</td>
<td>116</td>
<td>80-300</td>
</tr>
<tr>
<td>Basal ARR</td>
<td>64.5</td>
<td/>
<td>33.1</td>
<td/>
</tr>
<tr>
<td>Dexamethasone suppression test (1 mg): Cortisol (ng/mL)<sup><xref ref-type="table-fn" rid="table-fn3-1066896911427036">b</xref></sup></td>
<td>262</td>
<td>1161</td>
<td>24.8</td>
<td/>
</tr>
<tr>
<td>Saline infusion test: Aldosterone (pg/mL)</td>
<td>95</td>
<td/>
<td>65</td>
<td/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1066896911427036"><p>Abbreviations: ACTH, adrenocorticotropic hormone; UFC, urinary free cortisol; DHEA, dehydroepiandrosterone; 17-OHP, 17-hydroxyprogesterone; ARR, aldosterone to plasma renin activity ratio.</p></fn>
<fn id="table-fn2-1066896911427036">
<label>a</label>
<p>Under oral replacement 48 mEq/d and following 4 weeks of no pharmacological interference.</p></fn>
<fn id="table-fn3-1066896911427036">
<label>b</label>
<p>To convert to nmol/L, divide by 10 and multiply by 27.59.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>A <sup>131</sup>I-6-β-iodomethyl-norcholesterol scan was performed, showing an increased uptake at left adrenal level, without functional inhibition of the controlateral adrenal gland (<xref ref-type="fig" rid="fig1-1066896911427036">Figure 1</xref>). The patient underwent laparoscopic surgery. During surgery, an adrenal adenoma of 2 cm was removed. The cut surface of the tumor was yellow, which is typical of aldosterone-secreting adenomas.</p>
<p>Histologically, a cortical neoplasm with spironolactone bodies was found (<xref ref-type="fig" rid="fig2-1066896911427036">Figure 2</xref>). According to the Weiss score system, the following findings were noted: low nuclear grade with focal high nuclear grade areas, mitotic rate of 4 per 50 high-power field, no atypical mitotic figures, eosinophilic tumor cell cytoplasm in more than 75% of all tumor cells, diffuse architecture, no necrosis, no venous or sinusoidal invasion, and no capsular invasion (<xref ref-type="fig" rid="fig2-1066896911427036">Figure 2</xref>). A final Weiss score less than 3 and the small dimension indicated a benign neoplasm.</p>
<fig id="fig2-1066896911427036" position="float">
<label>Figure 2.</label>
<caption><p>Cortical neoplasm showing sipronolactone bodies (upper panel, arrows) and the unbroken capsula of the tumor (hematoxylin–eosin; lower panel)</p></caption>
<graphic xlink:href="10.1177_1066896911427036-fig2.tif"/>
</fig>
<p>Glucocorticoid replacement therapy was required immediately after surgery and then gradually stopped. The right adrenal gland was functioning normally. Potassium supplementation was gradually stopped and normokaliemia was present at the next controls (<xref ref-type="table" rid="table1-1066896911427036">Table 1</xref>).</p>
<p>Four months after the surgical procedure, a 1 mg dexamethasone suppression test was repeated; cortisol values were normal, and the AAR was normalized, as well as aldosterone values following saline load test (<xref ref-type="table" rid="table1-1066896911427036">Table 1</xref>). Arterial blood pressure was better controlled by antihypertensive therapy, which was markedly reduced, as follows: atenolol (50 mg/d), candesartan and hydrochlorothiazide (16 mg + 12.5 mg/d, respectively).</p>
</sec>
<sec id="section4-1066896911427036" sec-type="discussion">
<title>Discussion</title>
<p>Diagnosis of Cushing’s syndrome, as well as of primary hyperaldosteronism, associated with adrenal adenoma is not always easy to perform, especially when it is not associated with strong clinical evidence. Moreover, by performing a PubMed research through MEDLINE starting from 1970 up to 2011, we found 37 reports of well-described co-secretion of both cortisol and aldosterone from adrenal tumors.<sup><xref ref-type="bibr" rid="bibr2-1066896911427036">2</xref><xref ref-type="bibr" rid="bibr3-1066896911427036"/><xref ref-type="bibr" rid="bibr4-1066896911427036"/><xref ref-type="bibr" rid="bibr5-1066896911427036"/><xref ref-type="bibr" rid="bibr6-1066896911427036"/><xref ref-type="bibr" rid="bibr7-1066896911427036"/><xref ref-type="bibr" rid="bibr8-1066896911427036"/><xref ref-type="bibr" rid="bibr9-1066896911427036"/><xref ref-type="bibr" rid="bibr10-1066896911427036"/><xref ref-type="bibr" rid="bibr11-1066896911427036"/>-<xref ref-type="bibr" rid="bibr12-1066896911427036">12</xref></sup></p>
<p>In the case presented here, a possible confounding element was the presence of obesity, which could justify both type 2 diabetes and uncontrolled hypertension. The diagnosis was made because of the presence of an adrenal incidentaloma.</p>
<p>Späth et al<sup><xref ref-type="bibr" rid="bibr13-1066896911427036">13</xref></sup> published data from 8 patients followed in the past 10 years, with co-secretion of both cortisol and aldosterone by a unilateral adrenal tumor or adrenal hyperplasia. Tests used to screen aldosterone secretion are quite similar to the investigations used in our case. On the contrary, cortisol secretion by adrenal was differently assessed (ie, no dexamethasone suppression test, but only stimulatory tests). For this reason, even though we do not agree with the methods applied in this article, we agree with the authors on the general concept that patients with adrenal tumors must be screened for excess of different hormonal secretions.<sup><xref ref-type="bibr" rid="bibr13-1066896911427036">13</xref></sup></p>
<p>It is still a matter of debate why adrenal adenomas are able to co-secrete 2 different hormones, coming from different secretory pathways.</p>
<p>The adrenal cortex is divided into 3 functionally distinct zones, able to synthesize different hormones depending on the specific enzymatic pathways.<sup><xref ref-type="bibr" rid="bibr14-1066896911427036">14</xref></sup> To date, the reason why adrenal adenomas can express multiple different enzymatic pathways is still unknown.<sup><xref ref-type="bibr" rid="bibr15-1066896911427036">15</xref>,<xref ref-type="bibr" rid="bibr16-1066896911427036">16</xref></sup> Studies performed in fetal primates have shown that each adrenal zone may acquire the capacity to synthesize specific hormones during gestational age.<sup><xref ref-type="bibr" rid="bibr14-1066896911427036">14</xref></sup> Whether this may also occur in humans is unknown.</p>
<p>Aldosterone-secreting adenomas have a typical golden yellow cut surface,<sup><xref ref-type="bibr" rid="bibr17-1066896911427036">17</xref></sup> even though from the histological point of view, it is very difficult to distinguish aldosterone- from cortisol-secreting forms. The formation of spironolactone (S) bodies is induced by S through direct and indirect effects of S on the zona glomerulosa (zG).<sup><xref ref-type="bibr" rid="bibr18-1066896911427036">18</xref></sup> The indirect effects are thought to be mediated through stimulation of zG cells by a reactivated deficiency because of sodium diuresis after the administration of S. The direct effects of S have been hypothesized as being based on the turnover of endoplasmic reticulum of zG cells.<sup><xref ref-type="bibr" rid="bibr18-1066896911427036">18</xref></sup> S bodies were found in the adrenal cortices of patients affected by Conn’s syndrome or treated with S.<sup><xref ref-type="bibr" rid="bibr19-1066896911427036">19</xref></sup> Interestingly, in this case, the cytoplasm of the tumor cells contained structures resembling spironolactone bodies, but the patient had never had treatment with S. To our knowledge, this is the first case described in the literature, and the pathophysiological mechanism is unknown.</p>
<p>Other techniques, such as immunohistochemical analyses, can be used to identify aldosterone-producing adenomas,<sup><xref ref-type="bibr" rid="bibr3-1066896911427036">3</xref></sup> even though there is no general agreement about the sensitivity of these antibodies.</p>
<p>Our case report emphasizes the need to preoperatively assess whether an adenoma is able to secrete both aldosterone and cortisol in order to avoid a possible postoperative adrenal insufficiency. Very few cases focusing on the development of adrenal insufficiency in patients undergoing Conn’s syndrome surgery have, however, been reported in the literature.<sup><xref ref-type="bibr" rid="bibr20-1066896911427036">20</xref></sup></p>
<p>In conclusion, this suggests that all patients undergoing adrenal surgery for Conn’s syndrome should be screened for glucocorticoid activity.</p>
</sec>
</body>
<back>
<ack><p>Thanks to Dr Leonardo Rasciti, who is in charge of the approval of the “Group for Diagnosis and Treatment of Incidentally Discovered Adrenal Masses”, approved at the S. Orsola-Malpighi Hospital in May 2010.</p></ack>
<fn-group>
<fn fn-type="conflict"><p>The author(s) declared no potential conflicts of interests with respect to the research, authorship, and/or publication of this article.</p></fn>
<fn fn-type="financial-disclosure"><p>The author(s) received no financial support for the research, authorship, and/or publication of this article.</p></fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1066896911427036">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Omura</surname><given-names>M</given-names></name>
<name><surname>Saito</surname><given-names>J</given-names></name>
<name><surname>Yamaguchi</surname><given-names>K</given-names></name>
<name><surname>Kakuta</surname><given-names>Y</given-names></name>
<name><surname>Nishikawa</surname><given-names>T</given-names></name>
</person-group>. <article-title>Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan</article-title>. <source>Hypertens Res</source>. <year>2004</year>;<volume>27</volume>:<fpage>193</fpage>-<lpage>202</lpage>.</citation>
</ref>
<ref id="bibr2-1066896911427036">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Honda</surname><given-names>T</given-names></name>
<name><surname>Nakamura</surname><given-names>T</given-names></name>
<name><surname>Saito</surname><given-names>Y</given-names></name>
<name><surname>Ohyama</surname><given-names>Y</given-names></name>
<name><surname>Sumino</surname><given-names>H</given-names></name>
<name><surname>Kurabayashi</surname><given-names>M</given-names></name>
</person-group>. <article-title>Combined primary aldosteronism and preclinical Cushing’s syndrome: an unusual case presentation of adrenal adenoma</article-title>. <source>Hypertens Res</source>. <year>2001</year>;<volume>24</volume>:<fpage>72372</fpage>-<lpage>72376</lpage>.</citation>
</ref>
<ref id="bibr3-1066896911427036">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Suzuki</surname><given-names>J</given-names></name>
<name><surname>Otsuka</surname><given-names>F</given-names></name>
<name><surname>Inagaki</surname><given-names>K</given-names></name>
<etal/>
</person-group>. <article-title>Primary aldosteronism caused by a unilateral adrenal adenoma accompanied by autonomous cortisol secretion</article-title>. <source>Hypertens Res</source>. <year>2007</year>;<volume>30</volume>: <fpage>367</fpage>-<lpage>373</lpage>.</citation>
</ref>
<ref id="bibr4-1066896911427036">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hogan</surname><given-names>MJ</given-names></name>
<name><surname>Schambelan</surname><given-names>M</given-names></name>
<name><surname>Biglieri</surname><given-names>EG</given-names></name>
</person-group>. <article-title>Concurrent hypercortisolism and hypermineralocorticoidism</article-title>. <source>Am J Med</source>. <year>1977</year>; <volume>62</volume>:<fpage>777</fpage>-<lpage>782</lpage>.</citation>
</ref>
<ref id="bibr5-1066896911427036">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Komiya</surname><given-names>I</given-names></name>
<name><surname>Koizumi</surname><given-names>Y</given-names></name>
<name><surname>Kobayashi</surname><given-names>R</given-names></name>
<name><surname>Kotani</surname><given-names>M</given-names></name>
<name><surname>Yamada</surname><given-names>T</given-names></name>
<name><surname>Maruyama</surname><given-names>Y</given-names></name>
</person-group>. <article-title>Concurrent hypersecretion of aldosterone and cortisol from the adrenal cortical adenoma</article-title>. <source>Am J Med</source>. <year>1979</year>;<volume>67</volume>:<fpage>516</fpage>-<lpage>528</lpage>.</citation>
</ref>
<ref id="bibr6-1066896911427036">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Baert</surname><given-names>D</given-names></name>
<name><surname>Nobels</surname><given-names>F</given-names></name>
<name><surname>Van Crombrugge</surname><given-names>P</given-names></name>
</person-group>. <article-title>Combined Conn’s and Cushing’s syndrome: an unusual presentation of adrenal adenoma</article-title>. <source>Acta Clin Belg</source>. <year>1995</year>;<volume>50</volume>:<fpage>310</fpage>-<lpage>313</lpage>.</citation>
</ref>
<ref id="bibr7-1066896911427036">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Makino</surname><given-names>S</given-names></name>
<name><surname>Oda</surname><given-names>S</given-names></name>
<name><surname>Saka</surname><given-names>T</given-names></name>
<name><surname>Yasukawa</surname><given-names>M</given-names></name>
<name><surname>Komatsu</surname><given-names>F</given-names></name>
<name><surname>Sasano</surname><given-names>H</given-names></name>
</person-group>. <article-title>A case of aldosterone-producing adrenocortical adenoma associated with preclinical Cushing’s syndrome and hypersecretion of parathyroid hormone</article-title>. <source>Endocr J</source>. <year>2001</year>;<volume>48</volume>:<fpage>103</fpage>-<lpage>111</lpage>.</citation>
</ref>
<ref id="bibr8-1066896911427036">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Honda</surname><given-names>T</given-names></name>
<name><surname>Nakamura</surname><given-names>T</given-names></name>
<name><surname>Saito</surname><given-names>Y</given-names></name>
<name><surname>Ohyama</surname><given-names>Y</given-names></name>
<name><surname>Sumino</surname><given-names>H</given-names></name>
<name><surname>Kurabayashi</surname><given-names>M</given-names></name>
</person-group>. <article-title>Combined primary aldosteronism and preclinical Cushing’s syndrome: an unusual case presentation of adrenal adenoma</article-title>. <source>Hypertens Res</source>. <year>2001</year>;<volume>24</volume>:<fpage>723</fpage>-<lpage>726</lpage>.</citation>
</ref>
<ref id="bibr9-1066896911427036">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tanaka</surname><given-names>M</given-names></name>
<name><surname>Izeki</surname><given-names>M</given-names></name>
<name><surname>Miyazaki</surname><given-names>Y</given-names></name>
<etal/>
</person-group>. <article-title>Combined primary aldosteronism and Cushing’s syndrome due to a single adrenocortical adenoma complicated by Hashimoto’s thyroiditis</article-title>. <source>Intern Med</source>. <year>2001</year>;<volume>41</volume>:<fpage>967</fpage>-<lpage>971</lpage>.</citation>
</ref>
<ref id="bibr10-1066896911427036">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Adachi</surname><given-names>J</given-names></name>
<name><surname>Hirai</surname><given-names>Y</given-names></name>
<name><surname>Terui</surname><given-names>K</given-names></name>
<etal/>
</person-group>. <article-title>A report of 7 cases of adrenal tumors secreting both cortisol and aldosterone</article-title>. <source>Intern Med</source>. <year>2003</year>;<volume>42</volume>:<fpage>714</fpage>-<lpage>718</lpage>.</citation>
</ref>
<ref id="bibr11-1066896911427036">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sugawara</surname><given-names>A</given-names></name>
<name><surname>Takeuchi</surname><given-names>K</given-names></name>
<name><surname>Suzuki</surname><given-names>T</given-names></name>
<name><surname>Itoi</surname><given-names>K</given-names></name>
<name><surname>Sasano</surname><given-names>H</given-names></name>
<name><surname>Ito</surname><given-names>S</given-names></name>
</person-group>. <article-title>A case of aldosterone-producing adrenocortical adenoma associated with a probable post-operative adrenal crisis: histopathological analyses of the adrenal gland</article-title>. <source>Hypertens Res</source>. <year>2003</year>;<volume>26</volume>:<fpage>663</fpage>-<lpage>668</lpage>.</citation>
</ref>
<ref id="bibr12-1066896911427036">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fujii</surname><given-names>H</given-names></name>
<name><surname>Kamide</surname><given-names>K</given-names></name>
<name><surname>Miyake</surname><given-names>O</given-names></name>
<etal/>
</person-group>. <article-title>Primary aldosteronism combined with preclinical Cushing’s syndrome in an elderly patient</article-title>. <source>Circ J</source>. <year>2003</year>;<volume>69</volume>:<fpage>1425</fpage>-<lpage>1427</lpage>.</citation>
</ref>
<ref id="bibr13-1066896911427036">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Späth</surname><given-names>M</given-names></name>
<name><surname>Korovkin</surname><given-names>S</given-names></name>
<name><surname>Antke</surname><given-names>C</given-names></name>
<name><surname>Anlauf</surname><given-names>M</given-names></name>
<name><surname>Willenberg</surname><given-names>HS</given-names></name>
</person-group>. <article-title>Aldosterone- and cortisol-co-secreting adrenal tumors: the lost subtype of primary aldosteronism</article-title>. <source>Eur J Endocrinol</source>. <year>2011</year>;<volume>164</volume>:<fpage>447</fpage>-<lpage>455</lpage>.</citation>
</ref>
<ref id="bibr14-1066896911427036">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Coulter</surname><given-names>CL</given-names></name>
<name><surname>Jaffe</surname><given-names>RB</given-names></name>
</person-group>. <article-title>Functional maturation of the primate fetal adrenal in vivo: Specific zonal localization and developmental regulation of CYP21A2 (P450c21) and CYP11B1/CYP11B2 (P450c11/aldosterone synthase) lead to integrated concept of zonal and temporal steroid biosynthesis</article-title>. <source>Endocrinology</source>. <year>1998</year>;<volume>139</volume>:<fpage>5144</fpage>-<lpage>5150</lpage>.</citation>
</ref>
<ref id="bibr15-1066896911427036">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gomez-Sanchez</surname><given-names>CE</given-names></name>
<name><surname>Gill</surname><given-names>JR</given-names><suffix>Jr</suffix></name>
<name><surname>Ganguly</surname><given-names>A</given-names></name>
<name><surname>Gordon</surname><given-names>RD</given-names></name>
</person-group>. <article-title>Glucocorticoid-suppressible aldosteronism: a disorder of the adrenal transitional zone</article-title>. <source>J Clin Endocrinol Metab</source>. <year>1988</year>;<volume>67</volume>:<fpage>444</fpage>-<lpage>448</lpage>.</citation>
</ref>
<ref id="bibr16-1066896911427036">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Connell</surname><given-names>JM</given-names></name>
<name><surname>Kenyon</surname><given-names>CJ</given-names></name>
<name><surname>Corrie</surname><given-names>JE</given-names></name>
<name><surname>Fraser</surname><given-names>R</given-names></name>
<name><surname>Watt</surname><given-names>R</given-names></name>
<name><surname>Lever</surname><given-names>AF</given-names></name>
</person-group>. <article-title>Dexamethasone-suppressible hyperaldosteronism. Adrenal transition cell hyperplasia?</article-title> <source>Hypertension</source>. <year>1986</year>;<volume>8</volume>:<fpage>669</fpage>-<lpage>676</lpage>.</citation>
</ref>
<ref id="bibr17-1066896911427036">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Omura</surname><given-names>M</given-names></name>
<name><surname>Sasano</surname><given-names>H</given-names></name>
<name><surname>Saito</surname><given-names>J</given-names></name>
<name><surname>Yamaguchi</surname><given-names>K</given-names></name>
<name><surname>Kakuta</surname><given-names>Y</given-names></name>
<name><surname>Nishikawa</surname><given-names>T</given-names></name>
</person-group>. <article-title>Clinical characteristics of aldosterone-producing microadenoma, macroadenoma, and idiopathic hyperaldosteronism in 93 patients with primary aldosteronism</article-title>. <source>Hypertens Res</source>. <year>2006</year>;<volume>29</volume>:<fpage>883</fpage>-<lpage>889</lpage>.</citation>
</ref>
<ref id="bibr18-1066896911427036">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cohn</surname><given-names>D</given-names></name>
<name><surname>Jackson</surname><given-names>RV</given-names></name>
<name><surname>Gordon</surname><given-names>RD</given-names></name>
</person-group>. <article-title>Factors affecting the frequency of occurrence of spironolactone bodies in aldosteronomas and non-tumorous cortex</article-title>. <source>Pathology</source>. <year>1983</year>;<volume>15</volume>:<fpage>273</fpage>-<lpage>277</lpage>.</citation>
</ref>
<ref id="bibr19-1066896911427036">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Janigan</surname><given-names>DT</given-names></name>
</person-group>. <article-title>Cytoplasmic bodies in the adrenal cortex of patients treated with spirolactone</article-title>. <source>Lancet</source>. <year>1963</year>;<volume>1</volume>:<fpage>850</fpage>-<lpage>852</lpage>.</citation>
</ref>
<ref id="bibr20-1066896911427036">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kønig</surname><given-names>KB</given-names></name>
<name><surname>Krarup</surname><given-names>T</given-names></name>
<name><surname>Lund</surname><given-names>JO</given-names></name>
</person-group>. <article-title>Adrenal insufficiency after unilateral adrenalectomy for primary hyperaldosteronism [in Danish]</article-title>. <source>Ugeskr Laeger</source>. <year>2002</year>;<volume>164</volume>:<fpage>340</fpage>-<lpage>342</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>